Survivin-derived peptides and use thereof

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/47 (2006.01) A61K 38/08 (2006.01) A61K 38/17 (2006.01) A61K 39/00 (2006.01) A61K 49/00 (2006.01) A61P 35/00 (2006.01) C07K 7/06 (2006.01) G01N 33/574 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2513104

MHC Class I-restricted peptides derived from the tumor associated antigen, survivin, which peptides are capable of binding to Class I HLA molecules at a high affinity, capable of eliciting INF-.gamma.-producing cells in a PBL population of a cancer patient and capable of in situ detection of cytotoxic T cells in a tumor tissue, therapeutic and diagnostic composition comprising the peptide and uses thereof.

L'invention concerne des peptides CMH de classe I restreints dérivés de l'antigène associé à une tumeur, la survivine, ces peptides étant capables de se lier à des molécules HLA de classe I avec une affinité élevée, de solliciter des cellules de production INF-?- dans une population de lymphocytes circulants (PBL) d'un patient atteint d'un cancer et de détecter in situ des lymphocytes T cytotoxiques dans un tissu tumoral. L'invention concerne également une composition thérapeutique et diagnostique comprenant le peptide et les utilisations desdits peptides.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Survivin-derived peptides and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Survivin-derived peptides and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Survivin-derived peptides and use thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1452240

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.